BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 32336415)

  • 1. Blastic Plasmacytoid Dendritic Cell Neoplasm: The Dermatologist's Perspective.
    Hirner JP; O'Malley JT; LeBoeuf NR
    Hematol Oncol Clin North Am; 2020 Jun; 34(3):501-509. PubMed ID: 32336415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations.
    Shumilov E; Mazzeo P; Ghandili S; Künstner A; Weidemann S; Banz Y; Ströbel P; Pollak M; Kolloch L; Beltraminelli H; Kerkhoff A; Mikesch JH; Schliemann C; Haase D; Wulf G; Legros M; Lenz G; Feldmeyer L; Pabst T; Witte H; Gebauer N; Bacher U
    Ann Hematol; 2024 May; 103(5):1587-1599. PubMed ID: 38194088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN): focus on the use of tagraxofusp and clinical considerations.
    Pemmaraju N; Madanat YF; Rizzieri D; Fazal S; Rampal R; Mannis G; Wang ES; Foran J; Lane AA
    Leuk Lymphoma; 2024 May; 65(5):548-559. PubMed ID: 38391126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blastic plasmacytoid dendritic cell tumor treated with DVT regimen: a case report and literature review].
    Shi J; Xu N; Niu Y; Jia SX; Yang CM; Fang MY
    Zhonghua Xue Ye Xue Za Zhi; 2024 Jan; 45(1):86-89. PubMed ID: 38527844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blastic plasmacytoid dendritic cell neoplasm in an adolescent female: a rare entity with challenging diagnosis and management.
    Agarwal A; Amit M; Chaffin J; Strobel A
    BMJ Case Rep; 2023 May; 16(5):. PubMed ID: 37258047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blastic plasmacytoid dendritic cell neoplasm mimicking dermatomyositis.
    Fay CJ; Iriarte C; Moslehi D; Sheets AR; LeBoeuf NR
    JAAD Case Rep; 2023 Sep; 39():70-73. PubMed ID: 37635862
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnosing and Treating Blastic Plasmacytoid Dendritic Cell Neoplasm in a Resource-Limited Setting.
    Khan F; Hashmi F; Ghahramanyan N; Baloyan E; Tamamyan G; Konopleva M; Pemmaraju N; Voskanyan A
    Oncology (Williston Park); 2024 Mar; 38(3):104-106. PubMed ID: 38517410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous blastic plasmacytoid dendritic cell neoplasm and myelofibrosis: A case report.
    Luo F; Li B; Li J; Li Y
    Oncol Lett; 2024 May; 27(5):220. PubMed ID: 38586204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A non-resolving bruise and the 'pearl necklace'-Blastic plasmacytoid dendritic cell neoplasm.
    Lam WK; Kong SY
    Br J Haematol; 2024 Apr; 204(4):1131. PubMed ID: 38323480
    [No Abstract]   [Full Text] [Related]  

  • 10. Yu Y-T, Chang K-C. Immunoblastoid blastic plasmacytoid dendritic cell neoplasm with MYC rearrangement. Blood. 2022;139(14):2257.
    Blood; 2023 Feb; 141(6):682. PubMed ID: 36757725
    [No Abstract]   [Full Text] [Related]  

  • 11. Severe tumor lysis syndrome during the induction therapy for the treatment of blastic plasmacytoid dendritic cell neoplasm arising from myelodysplastic/myeloproliferative neoplasms.
    Sagou K; Ito M; Kawamura Y; Ukai S; Goto M; Fukushima N; Ozeki K; Fukuyama R; Kohno A
    Clin Case Rep; 2021 Feb; 9(2):878-882. PubMed ID: 33598264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel IKZF1 rearrangement identified in a patient with blastic plasmacytoid dendritic cell neoplasm decreased haematopoietic stem cell function and promoted plasmacytoid dendritic cell abnormality.
    Yin L; Yu Q; Zhang H; Zhu H; Deng Z; Xing C; Wang P; Zeng X; Cheng Z; Sheng Y; Peng H
    Br J Haematol; 2024 Apr; ():. PubMed ID: 38616623
    [No Abstract]   [Full Text] [Related]  

  • 13. Blastic Plasmacytoid Dendritic-Cell Neoplasm.
    Gonzaga Y; Fontes M
    N Engl J Med; 2020 Nov; 383(22):2158. PubMed ID: 33252872
    [No Abstract]   [Full Text] [Related]  

  • 14. Blastic plasmacytoid dendritic cell neoplasms: results of an international survey on 398 adult patients.
    Laribi K; Baugier de Materre A; Sobh M; Cerroni L; Valentini CG; Aoki T; Suzuki R; Takeuchi K; Frankel AE; Cota C; Ghez D; Le Calloch R; Pagano L; Petrella T
    Blood Adv; 2020 Oct; 4(19):4838-4848. PubMed ID: 33027528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic Cell Leukemia: a Review.
    Tsagarakis NJ; Paterakis G
    Curr Oncol Rep; 2020 May; 22(6):55. PubMed ID: 32415624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival outcomes in blastic plasmacytoid dendritic cell neoplasm by first-line treatment and stem cell transplant.
    Yun S; Chan O; Kerr D; Vincelette ND; Idrees A; Mo Q; Sweet K; Lancet JE; Kharfan-Dabaja MA; Zhang L; Sokol L
    Blood Adv; 2020 Jul; 4(14):3435-3442. PubMed ID: 32722779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blastic Plasmacytoid Dendritic Cell Neoplasm: Case Report and Literature Overview.
    Kolerova A; Sergeeva I; Krinitsyna J; Pronkina N; Sizikova S; Filimonov P; Kryuchkova I
    Indian J Dermatol; 2020; 65(3):217-221. PubMed ID: 32565565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blastic Plasmacytoid Dendritic Cell Neoplasm in 2020 and Beyond.
    Lane AA
    Hematol Oncol Clin North Am; 2020 Jun; 34(3):xiii-xiv. PubMed ID: 32336426
    [No Abstract]   [Full Text] [Related]  

  • 19. Blastic Plasmacytoid Dendritic Cell Neoplasm in Children.
    Li Y; Sun V; Sun W; Pawlowska A
    Hematol Oncol Clin North Am; 2020 Jun; 34(3):601-612. PubMed ID: 32336423
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.